Zevra Therapeutics Newsroom

William Blair Maintains Zevra Therapeutics(ZVRA.US) With Buy Rating

Futu NewsOct 14 18:34

Buy Rating Affirmed for Zevra Therapeutics Based on Strong NPV and Future Market Potential

TipRanksOct 14 17:50

Guggenheim Initiates Zevra Therapeutics(ZVRA.US) With Buy Rating, Announces Target Price $20

Futu NewsOct 7 20:31

H.C. Wainwright Maintains Zevra Therapeutics(ZVRA.US) With Buy Rating, Raises Target Price to $20

Futu NewsSep 30 18:31

Zevra Therapeutics Analyst Ratings

BenzingaSep 30 18:29

Maxim Group Maintains Zevra Therapeutics(ZVRA.US) With Buy Rating, Raises Target Price to $25

Futu NewsSep 25 19:31

JMP Securities Maintains Zevra Therapeutics(ZVRA.US) With Buy Rating, Maintains Target Price $17

Futu NewsSep 25 12:32

Zevra Therapeutics Price Target Announced at $17.00/Share by JMP Securities

Dow JonesSep 24 21:35

Zevra Therapeutics Is Maintained at Buy by Maxim Group

Dow JonesSep 24 21:15

A Quick Look at Today's Ratings for Zevra Therapeutics(ZVRA.US), With a Forecast Between $17 to $25

Futu NewsSep 24 21:00

Roth MKM Keeps Their Buy Rating on Zevra Therapeutics (ZVRA)

TipRanksSep 24 19:59

William Blair Maintains Zevra Therapeutics(ZVRA.US) With Buy Rating

Futu NewsSep 21 02:31

Zevra Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow JonesSep 21 01:36

H.C. Wainwright Maintains Zevra Therapeutics(ZVRA.US) With Buy Rating, Maintains Target Price $18

Futu NewsSep 21 01:32

Zevra Therapeutics Analyst Ratings

BenzingaSep 21 01:27

Zevra Therapeutics Is Maintained at Buy by Canaccord Genuity

Dow JonesSep 19 03:07

Zevra Therapeutics Analyst Ratings

BenzingaSep 19 02:59

CCORF Maintains Zevra Therapeutics(ZVRA.US) With Buy Rating, Cuts Target Price to $22

Futu NewsSep 18 20:33

William Blair Maintains Zevra Therapeutics(ZVRA.US) With Buy Rating

Futu NewsSep 18 20:33

Analysts Offer Insights on Healthcare Companies: Inmune Bio (INMB) and Zevra Therapeutics (ZVRA)

TipRanksSep 18 19:44